Volume | 1,043,753 |
|
|||||
News | (4) | ||||||
Day High | 21.47 | Low High |
|||||
Day Low | 20.90 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Organon and Co | OGN | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
21.44 | 20.90 | 21.47 | 20.99 | 21.35 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
13,265 | 1,043,753 | US$ 21.18 | US$ 22,102,099 | - | 10.835 - 24.08 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:46:36 | 14 | US$ 20.86 | USD |
Organon (OGN) Options Flow Summary
Organon and Co Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
5.37B | 255.64M | - | 6.26B | 1.02B | 4.00 | 5.25 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Organon News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OGN Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 21.49 | 21.98 | 20.90 | 21.74 | 1,503,667 | -0.39 | -1.81% |
1 Month | 18.43 | 21.98 | 18.11 | 20.35 | 2,194,644 | 2.67 | 14.49% |
3 Months | 17.50 | 21.98 | 17.25 | 18.88 | 2,098,772 | 3.60 | 20.57% |
6 Months | 11.27 | 21.98 | 10.835 | 16.03 | 3,034,140 | 9.83 | 87.22% |
1 Year | 20.57 | 24.08 | 10.835 | 16.77 | 3,203,253 | 0.53 | 2.58% |
3 Years | 34.20 | 39.475 | 10.835 | 24.59 | 2,546,928 | -13.10 | -38.30% |
5 Years | 34.20 | 39.475 | 10.835 | 24.59 | 2,546,928 | -13.10 | -38.30% |
Organon Description
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. |